Frontiers in Psychiatry | Psychopharmacology

Original Research

Published on 19 May 2023

Effects of varenicline on the serum levels of olanzapine in male patients with Schizophrenia: a randomized controlled trial

in Psychopharmacology

Mengling Deng
Zhi Yang
Yanfei Ni
Lingli Zhu
Jiating Xu
Lifeng Zheng
Bo Zhou

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1142419

2,139 views

Original Research

Published on 18 May 2023

Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system

in Psychopharmacology

Tigran Makunts
Diane Dahill
Lisa Jerome
Alberdina de Boer
Ruben Abagyan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1149766

4,077 views
4 citations

Case Report

Published on 15 May 2023

Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa

in Psychopharmacology

Johanna Louise Keeler
Janet Treasure
Hubertus Himmerich
Madeline Brendle
Claire Moore
Reid Robison

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1181447

3,833 views
19 citations

Original Research

Published on 12 May 2023

Adherence to antipsychotic laboratory monitoring guidelines in children and youth: a population-based study

in Psychopharmacology

Tony Antoniou
Tianru Wang
Kathleen Pajer
William Gardner
Yona Lunsky
Melanie Penner
Mina Tadrous
Muhammad Mamdani
David N. Juurlink
Tara Gomes

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1172559

3,897 views
3 citations

Original Research

Published on 10 May 2023

Mapping metabolite change in the mouse brain after esketamine injection by ambient mass spectrometry imaging and metabolomics

in Psychopharmacology

Guan-Xi Liu
Ze-Lin Li
Su-Yan Lin
Qian Wang
Zheng-Yi Luo
Kai Wu
Yan-Lin Zhou
Yu-Ping Ning

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1109344

2,859 views
5 citations

Correction

Published on 09 May 2023

Corrigendum: Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study

in Psychopharmacology

Karl Kristjan Kaup
Madis Vasser
Kadi Tulver
Mari Munk
Juhan Pikamäe
Jaan Aru

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1198103

1,188 views
2 citations

Review

Published on 27 Apr 2023

The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review

in Psychopharmacology

Charlotte E. Goldfine
Jeremiah J. Tom
Dana D. Im
Benjamin Yudkoff
Amit Anand
Joseph J. Taylor
Peter R. Chai
Joji Suzuki

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1141836

17,746 views
14 citations

Original Research

Published on 25 Apr 2023

Agomelatine's antiglycoxidative action—In vitro and in silico research and systematic literature review

in Psychopharmacology

Miłosz Nesterowicz
Kamil Klaudiusz Lauko
Małgorzata Żendzian-Piotrowska
Jerzy Robert Ładny
Anna Zalewska
Mateusz Maciejczyk

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1164459

3,099 views
6 citations

Case Report

Published on 21 Apr 2023

Case series: Continued remission of PTSD symptoms after discontinuation of prazosin

in Psychopharmacology

Christie Richardson
Jonathan Yuh
Jing Su
Martin Forsberg

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1172754

8,460 views
4 citations

Editorial

Published on 18 Apr 2023

Editorial: Assessing the consequences of antidepressant treatments

in Psychopharmacology

Markus Kosel
Chong Guang Ng
Norio Yasui-Furukori

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1185678

1,666 views

Clinical Trial

Published on 18 Apr 2023

Assessing the effect of Alpinia galanga extract on the treatment of SSRI-induced erectile dysfunction: A randomized triple-blind clinical trial

in Psychopharmacology

Farzad Akbarzadeh
Mahboubeh Eslamzadeh
Ghazal Behravan
Alireza Ebrahimi
Seyed Ahmad Emami
Atefe Gilan
Najme Sadat Hoseinian

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1105828

8,209 views
3 citations

Review

Published on 17 Apr 2023

Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase D

in Psychopharmacology

George R. Uhl

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1031283

2,113 views

Brief Research Report

Published on 14 Apr 2023

Perspectives on the therapeutic potential of MDMA: A nation-wide exploratory survey among substance users

in Psychopharmacology

Jennifer L. Jones

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1096298

5,131 views
4 citations

Case Report

Published on 14 Apr 2023

Case series: Cariprazine in early-onset schizophrenia

in Psychopharmacology

Elena Ivanova
Desislava Maslinkova
Nadia Polnareva
Vihra Milanova

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1155518

2,526 views
4 citations

Case Report

Published on 13 Apr 2023

Ketamine as an alternative to ECT in catatonia in elderly women with bipolar disorder: A case report

in Psychopharmacology

Shanthi Sarma
Arulmathy Arunachalam
Memunatu Kamara
Grace Branjerdporn

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1138772

4,781 views
3 citations

Original Research

Published on 06 Apr 2023

Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database

in Psychopharmacology

Giuseppe Cicala
Renato de Filippis
Maria Antonietta Barbieri
Paola Maria Cutroneo
Pasquale De Fazio
Georgios Schoretsanitis
Edoardo Spina

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1130636

3,263 views
9 citations